Author

Ankita Devi

Observed name: Devi, Ankita

Institutions: National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

Observed institutions: National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

ORCID: 0000-0002-4581-9365

Observed ORCID: 0000-0002-4581-9365

OpenAlex ID: A5109667804

Spirocyclic compounds: potential drug leads in the fight against Mycobacterium tuberculosis

2025 · Pardeep Kumar, Anuradha Singampalli, et al. · Future Medicinal Chemistry · 20

Exploration of New Dihydroindazole Derivatives as Promising Anti‐TB Agents: Design, Synthesis, In Silico, and Biological Evaluation

2025 · Pardeep Kumar, Pradip Malik, et al. · Archiv der Pharmazie · 9

Urolithin improves α-synuclein aggregation and DNMT1 expression in rotenone model of Parkinson’s disease

2025 · Ankita Devi, Sharon Munagalasetty, et al. · NeuroToxicology · 8

Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation

2025 · Pardeep Kumar, Anuradha Singampalli, et al. · ChemMedChem · 6

Structure–activity relationship–driven lead optimization of pyrazole hydrazide–hydrazone analogues as potent antimycobacterial agents: in vitro and in silico studies

2026 · Pardeep Kumar, Anuradha Singampalli, et al. · Bioorganic & Medicinal Chemistry Letters · 3

Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors

2025 · Pardeep Kumar, Anuradha Singampalli, et al. · Future Medicinal Chemistry · 2

Computational small molecule drug discovery for multidrug-resistant tuberculosis: emerging targets and recent medicinal chemistry advances

2026 · Pardeep Kumar, Ankita Devi, et al. · Bioorganic Chemistry · 1

Urolithin A Reverses Intranigral Rotenone-Generated Parkinsonism by Modulating DNA Methyltransferase 1 and α-Synuclein Axis in Rats

2026 · Ankita Devi, Shashi Bala Singh, et al. · ACS Chemical Neuroscience · 1

Expanding the tetrazole space: medicinal chemistry, biological diversity and structure–activity relationships

2026 · Anuradha Singampalli, Pardeep Kumar, et al. · Future Medicinal Chemistry

Expanding the tetrazole space: medicinal chemistry, biological diversity and structure–activity relationships

2026 · Anuradha Singampalli, Pardeep Kumar, et al. · Figshare

Natural products in the management of type 2 diabetes mediated neurological complications

2026 · Rahul Kumar, Ankita Devi, et al. · Elsevier eBooks

Works count: 13

Citation count: 50

H-index: 4

I10-index: 1